Latest Executive Appointment News

Dimerix has completed adult patient recruitment in its Phase 3 ACTION3 trial for DMX-200, with a blinded review confirming the study remains statistically powered to demonstrate treatment efficacy. The company also appointed a new CFO and is negotiating up to US$50 million in non-dilutive funding.

NeuroScientific Biopharmaceuticals reported positive clinical responses in its StemSmart™ Special Access Program for fistulising Crohn’s disease and has initiated manufacturing technology transfer to support Phase 2 trials planned for late 2026.

Unico Silver has reported a 143% surge in its Joaquin project's mineral resource to 167 million ounces silver equivalent, reinforcing its status as a major silver developer. The company also progressed key pre-feasibility studies and expanded its investor reach with a US OTCQB listing.

Trade Window Holdings has announced the unexpected resignation of founding CEO AJ Smith due to illness, with COO Dewald van Rensburg stepping in as acting CEO. The board is currently evaluating options for a permanent replacement.

Nutritional Growth Solutions has appointed director Manik Pujara as interim CEO and CFO, replacing Andrew Grover who remains as nonexecutive chair. This leadership shuffle coincides with ongoing exploration of corporate opportunities.

St George Mining has appointed Carla Grasso as Principal Geologist to spearhead mine planning at its Araxá Rare Earths-Niobium Project, following a major resource upgrade. This move signals a decisive step towards advancing economic studies and potential mining operations in Brazil.

Ovanti Limited has terminated its SPAC transaction with Miluna Acquisition Corp, shifting focus to alternative NASDAQ listing opportunities better aligned with its U.S. expansion strategy. The company is strengthening leadership and accelerating its U.S. growth plans.

Yojee Limited reported a 9% revenue increase driven by software activities, while net losses widened due to accelerated investment in its MOSAIC platform and joint venture costs. The company maintains a robust cash balance and has strengthened its leadership ahead of a mid-2026 commercial launch.

Alpha HPA Limited reported a $22.5 million loss for the half-year ending December 2025, driven by ongoing investment in its HPA First Project. Despite the loss, strong demand from semiconductor and battery sectors and a recent $225 million capital raise position the company for significant growth.

MyEco Group has reported a 38% improvement in profit before tax and a 51% rise in normalised EBITDA for the first half of FY26, driven by operational restructuring and targeted sales growth. The company’s refreshed leadership team and strategic priorities set the stage for further expansion in sustainable packaging markets.

Eminence Minerals Limited has issued 2.7 million unquoted CEO performance rights as part of a new executive appointment, utilising its 15% placement capacity without shareholder approval.

Orthocell Limited has reported a record half-year revenue of $6.2 million, driven by accelerating sales of its regenerative medicine products and expanding global footprint. The company’s US commercial launch of Remplir™ is gaining momentum alongside new market entries in Canada, Hong Kong, and Europe.